NF1 and neoplasm: Mutations in multiple genes encoding the components of the RAS/MAPK pathway predispose patients to develop clinical features that overlap with those of NF1, e.g. Legius syndrome, Noonan syndrome inter alia, and the majority of these conditions are associated with tumours [39].